Factor | Lugsomya2018 (20009)

10.1089/mdr.2017.0042

Therapeutic tobramycin use

Swine | Grower-finisher

1

Description

Tobramycin use broken up by treatment group

Resistance Outcomes

Resistance Microbe Outcome
Tobramycin
/
Escherichia coli
See: Figure 2 AMR+ (%) AMR- (%) Total (n)
Therapeutic AMU 17.10 70
No AMU 20.90 67